지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이 논문의 연구 히스토리 (2)
- 이 논문의 후속연구가 궁금하신가요?
- 연관 학술논문 또는 학술발표를 통해 보다 발전된 연구결과를 확인하실 수 있습니다.
- 이 논문의 연구 히스토리 확인하기
초록· 키워드
오류제보하기
Background : Despite recent advances in diagnosis and treatment, pneumonia causes great morbidity and mortality and entails high healthcare costs. Levofloxacin is one of the recommended drugs for the treatment of pneumonia. However, the increase in the use of levofloxacin may lead to an increase in resistance to this medication. The purpose of this study was to evaluate the rate of levofloxacin use to prevent resistance to the drug as per the developed criteria (referenced with Micromedex®, KIMS® and KFDA) and to provide information for implementation of pharmaceutical intervention for the optimal intravenous-to-oral (IV-to-PO) switch. Methods : This study was conducted within pneumonia patients discharged from the pulmonology ward at the Ulsan University Hospital June 1, December 31, 2018. The evaluation criteria were as follow: treatment dose, duration of the treatment, potential drug-drug interactions (pDDIs), evaluation of implementation of essential examinations and adverse drug reaction (ADR) monitoring, and the optimal IV-to-PO switch. The electronic medical record (EMR) database was used to retrospectively collect data. Results : In total, 125 patients were included, of whom 17 were later excluded from the evaluation of the treatment period, and optimal IV-to-PO switch from death during the treatment. Dose adjustment according to renal function was required in 59 (47.2%) patients, four of whom received a suitable dose. The treatment period was appropriate in 66.7% patients. Also, 34.4% patients did not receive concomitant drugs that could interact with levofloxacin, and the implementation rate of essential examination was high except for therapeutic drug monitoring. Additionally, 46.3% of patients were suitable for the optimal IV-to-PO switch. Although no ADRs were reported during ADR monitoring, several symptoms including itching, and elevated LFT were recorded by the EMR. Conclusion : Through evaluating of use of levofloxacin in pneumonia patients, we confirmed that practical mediation by pharmacists and improvement of the system are necessary.
목차
등록된 정보가 없습니다.
참고문헌 (30)
참고문헌 신청
Welte T / 2012 / Clinical and economic burden of community-acquired pneumonia among adults in Europe / Thorax 67(1):71~79
Jokinen C / 1993 / Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland / American Journal of Epidemiology 137(9):977~988
Prina E / 2015 / Community-acquired pneumonia / The Lancet 386(9998):1097~1108
Quintiliani R / 1999 / Clinical role of fluoroquinolones in patients with respiratory tract infections / Infectious Diseases in Clinical Practice 8(4):S28~41
Chen DK / 1999 / Decreased susceptibility of streptococcus pneumoniae to fluoroquinolones in Canada / New England Journal of Medicine 341(4):233~239
Jokinen C / 1993 / Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland / American Journal of Epidemiology 137(9):977~988
Prina E / 2015 / Community-acquired pneumonia / The Lancet 386(9998):1097~1108
Quintiliani R / 1999 / Clinical role of fluoroquinolones in patients with respiratory tract infections / Infectious Diseases in Clinical Practice 8(4):S28~41
Chen DK / 1999 / Decreased susceptibility of streptococcus pneumoniae to fluoroquinolones in Canada / New England Journal of Medicine 341(4):233~239
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen
Blood Research
2022 .03
-
Association between the Levofloxacin Plasma Concentration and Neurological Adverse Events in an Elderly Patient
Journal of Clinical Neurology
2019 .01
-
Pharmacokinetic profiles of levofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits (Oryctolagus cuniculus)
Journal of Veterinary Science
2020 .03
-
Development and preliminary characterization of levofloxacin pharmaceutical cocrystals for dissolution rate enhancement
Journal of Pharmaceutical Investigation
2017 .11
-
Risk Factors Related to Serious Adverse Drug Reactions Reported through Electronic Submission during Hospitalization in Elderly Patients
Korean Journal of Family Medicine
2022 .03
-
단일 대학병원의 지역의약품안전센터에 보고된 소아청소년의 약물유해반응 분석
Allergy Asthma & Respiratory Diseases
2018 .01
-
Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease
Gut and Liver
2017 .01
-
High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
단일기관에서 전산을 통해 수집된 자발적 소아 약물유해반응 보고사례의 분석
Allergy Asthma & Respiratory Diseases
2016 .01
-
Incidence and Economic Burden of Adverse Drug Reactions in Hospitalization: A Prospective Study in Korea
Journal of Korean Medical Science
2023 .02
-
중동 호흡기 증후군 치료에 사용한 항바이러스제의 약물이상반응 발현양상 분석
병원약사회지
2017 .08
-
L-asparaginase 약물 유해 반응 보고 분석
한국임상약학회지
2017 .01
-
1차 항결핵제 약물이상반응 현황: 단일기관 약물이상사례 보고사례 기반 분석
대한내과학회지
2021 .10
-
중증피부과민반응에 대한 약물이상반응 보고자료의 분석
병원약사회지
2017 .01
-
Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance
Intestinal research
2022 .07
-
Severe Thrombocytopenia in a Patient with COVID-19
Infection and Chemotherapy
2020 .01
-
Proportion of Aspiration Pneumonia Cases Among Patients With Community-Acquired Pneumonia: A Single-Center Study in Korea
Annals of Rehabilitation Medicine
2019 .01
-
군 병원 입원환자의 환자참여 의지 영향 요인
군진간호연구
2021 .09
이 논문의 저자 정보
최근 본 자료
댓글(0)
0